Keywords: Treatment Response, DSC & DCE Perfusion
Motivation: Neoadjuvant chemotherapy (NCT) benefits select locally advanced rectal cancer (LARC) patients, with those achieving clinical complete response (cCR) potentially avoiding surgery.
Goal(s): To evaluate the efficacy of dynamic contrast-enhanced MRI (DCE-MRI) parameters and MRI tumor regression grade (MR-TRG) in predicting pathologic complete response (pCR) after NCT.
Approach: Retrospective analysis of 81 rectal cancer patients, assessing DCE-MRI parameters and MR-TRG.
Results: Ktrans and kep were significantly lower, while ve was higher in pCR patients, with AUCs of 0.763, 0.868, and 0.698, respectively. MR-TRG showed high specificity but limited sensitivity.
Impact: This study highlights DCE-MRI’s potential in noninvasively predicting complete response in rectal cancer, supporting personalized, less invasive management and enabling organ preservation strategies in responsive patients following neoadjuvant chemotherapy.
How to access this content:
For one year after publication, abstracts and videos are only open to registrants of this annual meeting. Registrants should use their existing login information. Non-registrant access can be purchased via the ISMRM E-Library.
After one year, current ISMRM & ISMRT members get free access to both the abstracts and videos. Non-members and non-registrants must purchase access via the ISMRM E-Library.
After two years, the meeting proceedings (abstracts) are opened to the public and require no login information. Videos remain behind password for access by members, registrants and E-Library customers.
Keywords